Beat Steffen
InvestorPrincipal at Novartis Venture Fund
Basel, Switzerland
Writes $5M – $10M checks · typically $7.5M
Find your path to Beat
530 people in our graph share verified history with Beat — schools, employers, funds. One of them is your warm intro.
Chris BischoffunlockedBeat: together at INSEAD (2001)
×2Beat: together at INSEAD
×9Beat: together at McKinsey & Company
About
Beat Steffen is a Managing Director at the Novartis Venture Fund. He previously held commercial roles at Novartis Pharmaceuticals in the US and Switzerland, launching products in the cardiovascular area, and earlier worked at McKinsey & Company in Zurich with pharmaceutical clients. He is a Swiss-trained physician specializing in cardiovascular surgery and intensive care and holds an MBA from INSEAD.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- NovartisManaging Director Novartis Venture Fundcurrent2021 — presentBasel, Switzerland
- NovartisPrincipal Novartis Venture Fund2015 — 2021Basel, Basel, Switzerland
- NovartisGlobal Franchise Head Critical Care ai2014 — 2015Basel, Basel, Switzerland
- NovartisGeneral Manager Serelaxin2013 — 2014Basel, Basel, Switzerland
- NovartisAssistant to Head of Pharma Division2011 — 2013
- NovartisHead Marketing General Medicines2009 — 2011
- NovartisAssociate Director Valturna2008 — 2009
- NovartisRegional Director West CV Specialty Sales2006 — 2008
- SpliceBioMember Board of Directorscurrent2021 — presentBarcelona, Catalonia, Spain
- Rappta TherapeuticsChairman of the Boardcurrent2020 — presentHelsinki Metropolitan Area
- Vivet TherapeuticsMember Board of Directorscurrent2019 — presentParis, Île-de-France, France
- UZH Life Sciences FundMember Board of Directorscurrent2022 — presentZurich, Switzerland
- UZH Life Sciences FundChairman of the Board2020 — 2022Zurich, Switzerland
- UZH Life Sciences FundMember Board of Directors2017 — 2020Zurich, Zurich, Switzerland
- binx healthMember Board of Directors2019 — 2020Boston, Massachusetts, United States
- Aelin TherapeuticsMember Board of Directors2017 — 2019Leuven, Flemish Region, Belgium
- McKinsey & CompanySenior Associate1999 — 2001
- University Hospital of ZurichResident in Cardiovascular Surgery1995 — 1998
Skills & more
Pharmaceutical Sales28Sales Effectiveness27Market Access40Oncology20Cardiology15Medicine2Clinical Development15Diabetes2Biotechnology7Neurology2RheumatologyProduct Launch22
+12 more
EndocrinologyClinical TrialsInfectious DiseasesHospital SalesGastroenterologyLifesciencesRegulatory AffairsNephrologyPharmaceutical IndustryDermatologyGlobal MarketingUrologyFrom Beat's professional profile.
Investments
Investor
RapptaRappta TherapeuticsSplice Bio
Sources: the firm's website · curated public sources.
Colleagues at Novartis Venture Fund
Adam Cotton
Principal at the Novartis Venture Fund
Anís
Head of Scoping, Pharma at Deep Science Ventures
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Campbell Murray
Advisor
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Network5
Aaron Nelson
Partner at Novo Holdings
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Florian Muellershausen
Managing Director at Novartis Venture Fund
Investors connected to Beat in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Beat Steffen?
- Beat Steffen is a Managing Director at the Novartis Venture Fund. He previously held commercial roles at Novartis Pharmaceuticals in the US and Switzerland, launching products in the cardiovascular area, and earlier worked at McKinsey & Company in Zurich with pharmaceutical clients. He is a Swiss-trained physician specializing in cardiovascular surgery and intensive care and holds an MBA from INSEAD.
- Where does Beat Steffen work?
- Beat Steffen is Principal at Novartis Venture Fund.
- What does Beat Steffen invest in?
- Beat Steffen invests in Biotech.
- What check size does Beat Steffen write?
- Beat Steffen typically writes checks of $5M – $10M.
- What companies has Beat Steffen invested in?
- Investments tracked here include Rappta, Rappta Therapeutics, Splice Bio.
- Where did Beat Steffen go to school?
- Beat Steffen studied at INSEAD (MBA, Finance); University of Zurich (Medical Doctor, Medicine).
Same school
Also attended INSEAD1,323
Alexandre ProtCo-founder & CEO of QontoSteve AnaviCo-founder & President of QontoPatrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index Ventures
+ 1,317 more
Also attended University of Zurich133
Christoph FreiPartner, Head of Energy at Emerald Technology Ventures AgAndy WeymannVenture Partner, Frontiers in Health & Bio Investments at Verve VenturesDavid FischerInvestor at FELIX CAPITALJohannes ClaussSerial Entrepreneur, Investor and Mentor at tokentus investment AGMartin ScherrerPartner & Head of Managed Funds at RedstonePatrik BrudererCFO at CV Labs
+ 127 more
Shared employers
Also worked at Novartis327
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 321 more
